• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[B型利钠肽与急性呼吸困难患者心力衰竭诊断中的临床判断]

[B-type natriuretic peptide and clinical judgement in the diagnosis of heart failure in patients presenting with acute dyspnoea].

作者信息

Knudsen Cathrine Wold, Westheim Arne, Omland Torbjørn

机构信息

Hjertemedisinsk avdeling, Ullevål universitetssykehus, 0407 Oslo.

出版信息

Tidsskr Nor Laegeforen. 2003 Aug 14;123(15):2045-8.

PMID:12934128
Abstract

BACKGROUND

B-type natriuretic peptide (BNP) is increased in left ventricular dysfunction and congestive heart failure e. The aim of the study was to determine the diagnostic accuracy of BNP and the degree to which BNP adds to clinical judgement in the diagnosis of heart failure.

MATERIAL AND METHODS

The BNP Multinational Study was a seven-centre prospective study of 1586 patients presenting to emergency departments with acute dyspnoea who had BNP levels measured with a rapid, point-of-care device on arrival. 1538 (97%) had pre-test probability of congestive heart failure determined from 0-100% by the attending physician in the emergency department who was blinded to the BNP levels. The final diagnosis was adjudicated by two independent cardiologists, also blinded to BNP results, who reviewed all clinical data and standardised congestive heart failure scores.

RESULTS

The final diagnosis was congestive heart failure in 722 (47%) patients. Pre-test probability of this condition > or = 80% as determined by the attending physician had a sensitivity of 49% and specificity of 96 % for correct diagnosis. BNP > or = 100 pg/ml had a sensitivity of 90% and a specificity of 73% for correct diagnosis. In determining the correct diagnosis (congestive heart failure or not), adding BNP to clinical judgement would have enhanced diagnostic accuracy from 74% to 81%.

INTERPRETATION

Measurement of BNP adds to the clinical information in the diagnosis of congestive heart failure in patients presenting with acute dyspnoea.

摘要

背景

B型利钠肽(BNP)在左心室功能不全和充血性心力衰竭时升高。本研究的目的是确定BNP的诊断准确性以及BNP在心力衰竭诊断中对临床判断的补充程度。

材料与方法

BNP多国研究是一项在7个中心进行的前瞻性研究,共纳入1586例因急性呼吸困难就诊于急诊科的患者,患者到达时使用快速床旁检测设备测定BNP水平。1538例(97%)患者的充血性心力衰竭预测试概率由急诊科主治医师根据0 - 100%进行判定,该主治医师对BNP水平不知情。最终诊断由两名独立的心脏病专家裁定,他们也对BNP结果不知情,他们审查了所有临床数据并对充血性心力衰竭评分进行了标准化。

结果

最终诊断为充血性心力衰竭的患者有722例(47%)。主治医师判定该疾病的预测试概率≥80%时,正确诊断的敏感性为49%,特异性为96%。BNP≥100 pg/ml时,正确诊断的敏感性为90%,特异性为73%。在确定正确诊断(是否为充血性心力衰竭)时,将BNP添加到临床判断中可使诊断准确性从74%提高到81%。

解读

对于因急性呼吸困难就诊的患者,测定BNP可增加充血性心力衰竭诊断中的临床信息。

相似文献

1
[B-type natriuretic peptide and clinical judgement in the diagnosis of heart failure in patients presenting with acute dyspnoea].[B型利钠肽与急性呼吸困难患者心力衰竭诊断中的临床判断]
Tidsskr Nor Laegeforen. 2003 Aug 14;123(15):2045-8.
2
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure.中段心房利钠肽与氨基末端 B 型利钠肽前体在心力衰竭诊断中的比较。
J Intern Med. 2010 Jan;267(1):119-29. doi: 10.1111/j.1365-2796.2009.02135.x. Epub 2009 Jun 27.
3
Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.用于急性呼吸困难诊断和预后的中区域前激素标志物:来自 BACH(急性心力衰竭生物标志物)试验的结果。
J Am Coll Cardiol. 2010 May 11;55(19):2062-76. doi: 10.1016/j.jacc.2010.02.025.
4
B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study.B型利钠肽与肾功能在心力衰竭诊断中的作用:来自“呼吸不畅”多国研究的分析
Am J Kidney Dis. 2003 Mar;41(3):571-9. doi: 10.1053/ajkd.2003.50118.
5
Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the breathing not properly multinational study.无心力衰竭的呼吸困难患者B型利钠肽浓度升高的预测因素:来自“呼吸不当”多国研究的分析
Ann Emerg Med. 2005 Jun;45(6):573-80. doi: 10.1016/j.annemergmed.2005.01.027.
6
Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea.系统性高血压对急性呼吸困难患者B型利钠肽诊断性能的影响。
Am J Cardiol. 2009 Oct 1;104(7):966-71. doi: 10.1016/j.amjcard.2009.05.039.
7
The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.急诊室中N端前B型利钠肽检测对急性呼吸困难患者的附加价值。
Eur J Intern Med. 2009 May;20(3):301-6. doi: 10.1016/j.ejim.2008.09.022. Epub 2008 Nov 17.
8
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.B型利钠肽在心力衰竭急诊诊断中的快速测定
N Engl J Med. 2002 Jul 18;347(3):161-7. doi: 10.1056/NEJMoa020233.
9
Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.急诊科心力衰竭门诊快速试验(REDHOT)的主要结果。一项关于B型利钠肽水平、急诊科决策以及呼吸急促患者结局的多中心研究。
J Am Coll Cardiol. 2004 Sep 15;44(6):1328-33. doi: 10.1016/j.jacc.2004.06.015.
10
How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study.肥胖如何影响B型利钠肽在急性心力衰竭诊断中的切点。来自“呼吸不畅”多国研究的结果。
Am Heart J. 2006 May;151(5):999-1005. doi: 10.1016/j.ahj.2005.10.011.

引用本文的文献

1
The utility of B-type natriuretic peptide in the diagnosis of heart failure in the emergency department: a systematic review.B型利钠肽在急诊科心力衰竭诊断中的应用:一项系统评价
BMC Emerg Med. 2007 Jun 26;7:6. doi: 10.1186/1471-227X-7-6.